Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Clinical trial NCT02544152 · TERMINATED
Trial details
- NCT number
- NCT02544152
- Sponsor
- Sucampo Pharma Americas, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-12-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.